Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takahiro Nakayama

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
The Oncologist|January 19, 2010
Therapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in JapanTakahiro Nakayama, Shinzaburo Noguchi
Pharmacology, Biochemistry, and Behavior|January 29, 2002
Involvement of microtubule integrity in memory impairment caused by colchicineTakahiro Nakayama, Tohru Sawada
The Biochemical Journal|June 1, 2017
Transcription regulation mechanism of the syntaxin 1A gene via protein kinase ATakahiro Nakayama, Kimio Akagawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 11, 2012
[Chemotherapy for breast cancer]Takahiro Nakayama, Shinzaburo Noguchi
Future Oncology (London, England)|July 3, 2020
Therapy options after CDK4/6 inhibitors for HR+, HER2- postmenopausal metastatic/recurrent breast cancer in Japan: a role for mammalian target of rapamycin inhibitors?Takahiro Nakayama, Fumie Fujisawa
Journal of Cell Science|March 17, 2012
Syntaxin 1C, a soluble form of syntaxin, attenuates membrane recycling by destabilizing microtubulesTakahiro Nakayama, Hiroyuki Kamiguchi, Kimio Akagawa
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 23, 2015
The cell- and tissue-specific transcription mechanism of the TATA-less syntaxin 1A geneTakahiro Nakayama, Katsuhiko Mikoshiba, Kimio Akagawa
Future Oncology (London, England)|December 21, 2024
CDK4/6 inhibitor plus endocrine therapy for advanced breast cancer: results from a web-based survey in JapanTakahiro Nakayama, Linghua Xu, Yasuaki Muramatsu
BMJ Case Reports|June 5, 2013
Analysis using histograms of muscle CT images in patients with Duchenne muscular dystrophyTakahiro Nakayama, Satoshi Kuru, Mitsuru Kawai
Development (Cambridge, England)|November 9, 2012
The PBAP remodeling complex is required for histone H3.3 replacement at chromatin boundaries and for boundary functionsTakahiro Nakayama, Tsukasa Shimojima, Susumu Hirose
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
The Oncologist|January 19, 2010
Therapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in JapanTakahiro Nakayama, Shinzaburo Noguchi
Pharmacology, Biochemistry, and Behavior|January 29, 2002
Involvement of microtubule integrity in memory impairment caused by colchicineTakahiro Nakayama, Tohru Sawada
The Biochemical Journal|June 1, 2017
Transcription regulation mechanism of the syntaxin 1A gene via protein kinase ATakahiro Nakayama, Kimio Akagawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 11, 2012
[Chemotherapy for breast cancer]Takahiro Nakayama, Shinzaburo Noguchi
Future Oncology (London, England)|July 3, 2020
Therapy options after CDK4/6 inhibitors for HR+, HER2- postmenopausal metastatic/recurrent breast cancer in Japan: a role for mammalian target of rapamycin inhibitors?Takahiro Nakayama, Fumie Fujisawa
Journal of Cell Science|March 17, 2012
Syntaxin 1C, a soluble form of syntaxin, attenuates membrane recycling by destabilizing microtubulesTakahiro Nakayama, Hiroyuki Kamiguchi, Kimio Akagawa
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 23, 2015
The cell- and tissue-specific transcription mechanism of the TATA-less syntaxin 1A geneTakahiro Nakayama, Katsuhiko Mikoshiba, Kimio Akagawa
Future Oncology (London, England)|December 21, 2024
CDK4/6 inhibitor plus endocrine therapy for advanced breast cancer: results from a web-based survey in JapanTakahiro Nakayama, Linghua Xu, Yasuaki Muramatsu
BMJ Case Reports|June 5, 2013
Analysis using histograms of muscle CT images in patients with Duchenne muscular dystrophyTakahiro Nakayama, Satoshi Kuru, Mitsuru Kawai
Development (Cambridge, England)|November 9, 2012
The PBAP remodeling complex is required for histone H3.3 replacement at chromatin boundaries and for boundary functionsTakahiro Nakayama, Tsukasa Shimojima, Susumu Hirose
Pageof 23